ARK Genomic Revolution ETF
Health/Biotechnology
ARKG
200 Central Avenue,Suite 220
St. Petersburg , FL, 33701
St. Petersburg , FL, 33701
Price
-
$ 26.41
0 %
-0.02
Dec 9, 2024
- Last Close
- Net Assets
-
$1.7B
Mar 21, 2024
- 52-Week High/Low
- $34.25 - $22.66
- Expense Ratio
- -
Link
Directors
Oct 11, 2023- Catherine D. Wood
- Scott R. Chichester
- Darlene T. DeRemer
- Robert G. Zack
Chief Compliance Officer
- Kellen Carter
Company Name |
Holding |
| More | 1.12 % |
Returns +
Q
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Q1 | -3.9% | 6.5% | -25% | -4.8% | -6.7% | 37.1% |
| Q2 | - | 13.4% | -31.4% | 20.2% | 66.8% | 4.5% |
| Q3 | - | -18.3% | 4.4% | 2.1% | 183.7% | -14.4% |
| Q4 | - | 21.7% | -14.1% | -3.9% | -87.3% | 13.6% |
Returns +
M
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -13.3% | 10.9% | - | - | - | - | - | - | - | - | - | - |
| 2023 | 19.4% | -9.9% | -0.9% | -3.7% | 9.2% | 7.8% | 11.5% | -15.1% | -13.6% | -17.4% | 20.5% | 18.3% |
Returns +
A
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.9% | 16.2% | -53.9% | 226.3% | -44% | 39.8% | -0.1% | 46.6% | -19.3% | -1.2% | -48.5% |